Effect of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on post-liver transplant mortality and major adverse cardiovascular events

被引:0
|
作者
Yost, Kelli Kosako [1 ]
Gomez, Paul [1 ]
Rangan, Pooja [1 ]
Fallon, Michael [1 ]
Nathan, Rohit [1 ]
Rubin, Moises Nevah [1 ]
Wong, Mark [1 ]
Wijarnpreecha, Karn [1 ]
Ai, Ma [1 ]
Han, Thanda [1 ]
机构
[1] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-490
引用
收藏
页码:S463 / S463
页数:1
相关论文
共 50 条
  • [1] GLUCAGON- LIKE PEPTIDE-1 RECEPTOR AGONISTS AND SODIUM- GLUCOSE COTRANSPORTER-2 INHIBITORS EFFECT ON NEW ONSET POST-LIVER TRANSPLANT MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Yost, Kelli Kosako
    Ali, Qumber
    Ghai, Megan B.
    Aboona, Majd
    Gomez, Paul
    Rangan, Pooja
    Nathan, Rohit
    Wong, Mark
    Wijarnpreecha, Karn
    Ilan, Moises
    Rubin, Nevah
    Fallon, Michael
    Han, Ma Ai Thanda
    HEPATOLOGY, 2023, 78 : S312 - S313
  • [2] Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
    North, Emily J.
    Newman, Jonathan D.
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (06) : 687 - 692
  • [3] Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
    Zheng, Katina
    Azhie, Amirhossein
    You, Xiaoting
    Naghibzadeh, Maryam
    Tan, Eunice
    Naimimohasses, Sara
    Sridhar, Vikas S.
    Gupta, Sarang
    Chen, Shiyi
    Dash, Satya
    Tsien, Cynthia
    Selzner, Nazia
    Lilly, Leslie
    Jaeckel, Elmar
    Woo, Minna
    Singh, Sunita
    Cherney, David
    Bhat, Mamatha
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4261 - 4272
  • [4] Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors benefits add up?
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Fragakis, Nikolaos
    Bernal-Lopez, Maria Rosa
    Gomez-Huelgas, Ricardo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 130 : 155 - 159
  • [5] Prescription of Sodium-glucose cotransporter-2 inhibitors and Glucagon-like peptide-1 receptor agonists among Veterans with diabetes and cardiovascular disease
    Qaisrani, Fatima
    Wu, Jingyi
    Eberly, Lauren
    Khatana, Sameed Ahmed
    CIRCULATION, 2024, 150
  • [6] Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
    Lin, Tzu-Yi
    Kang, Eugene Yu-Chuan
    Shao, Shih-Chieh
    Lai, Edward Chia-Cheng
    Garg, Sunir J.
    Chen, Kuan-Jen
    Kang, Je-Ho
    Wu, Wei-Chi
    Lai, Chi-Chun
    Hwang, Yih-Shiou
    DIABETES & METABOLISM JOURNAL, 2023, 47 (03) : 394 - 404
  • [7] Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes
    Riester, Melissa R.
    Zullo, Andrew R.
    Joshi, Richa
    Daiello, Lori A.
    Hayes, Kaleen N.
    Ko, Darae
    Kim, Dae Hyun
    Munshi, Medha
    Berry, Sarah D.
    DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3403 - 3417
  • [8] Cardiovascular outcomes with Glucagon-like Peptide-1 receptor agonists and Sodium-glucose Cotransporter-2 Inhibitors in patients with ischemic stroke in the community
    Sheffeh, Mohammad Ali
    Magana, Andres Estrada
    Medina-Inojosa, Jose
    Aviles, Laura Ortega
    Bianchettin, Rosana
    Medina-Inojosa, Betsy
    Klaas, James
    Brown, Robert
    Lopez-Jimenez, Francisco
    CIRCULATION, 2024, 150
  • [9] Patients' Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
    Banjara, Bidur
    Poudel, Nabin
    Garza, Kimberly B.
    Westrick, Salisa
    Whitley, Heather P.
    Redden, David
    Ngorsuraches, Surachat
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 3415 - 3428
  • [10] Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort
    Lu, Di-Fei
    Zheng, Rui
    Li, Ang
    Zhang, Jun-Qing
    WORLD JOURNAL OF DIABETES, 2025, 16 (02)